Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia

Recent papers from Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia

1. Implementation gaps in secondary prevention between coronary and cerebrovascular disease: a multicenter real-world studyEuropean Heart Journal · 2026
2. LEAP2 mediates long-term inhibition of orexigenic neurons of the hypothalamus in miceProceedings of the National Academy of Sciences · 2026
3. Medical cannabis for the treatment of insomniaCochrane library · 2026
4. Globalising the access to advanced molecular diagnostics of CNS tumors: Experience of the Molecular Neuro-Pathology (MNP) Outreach ConsortiumNeuro-Oncology · 2026
5. Recognition memory as a neuropsychological marker of progression in early-stage Alzheimer’s disease: a 24-month prospective cohort studyJournal of Clinical and Experimental Neuropsychology · 2026
6. Case Report: Selumetinib as a neoadjuvant treatment for the removal of a PNFrontiers in Pediatrics · 2026
7. Comparative Analysis of L‐Dopa and Deep Brain Stimulation on Bradykinesia Components in Parkinson's DiseaseMovement Disorders Clinical Practice · 2026
8. Transferrin Promotes Oligodendroglial Differentiation Independently of Iron Binding and ReleaseASN NEURO · 2026
9. Facial Nerve Preservation in Hannover IV Vestibular Schwannomas. What Factors Can Predict Facial Outcome?Neurology India · 2026
10. Novel blood lncRNA biomarkers associated with clinical severity and specific cognitive dimensions in Alzheimer's diseaseJournal of Alzheimer s Disease · 2026
11. Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trialThe Lancet · 2026
12. Reliability of psychiatric diagnoses in the 21st centuryFrontiers in Psychiatry · 2026
13. The burden of noncommunicable and injury-related nervous system disorders in the Americas, 1990–2023: an analysis of the Global Burden of Disease Study 2023The Lancet Regional Health - Americas · 2026
14. Modulating SPARC expression in mesenchymal stem cells improves MSCs-mediated skin regeneration and wound repairScientific Reports · 2026
15. Interleukin 6 Receptor Blockade for Relapse Prevention in Myelin Oligodendrocyte Glycoprotein Antibody–Associated DiseaseJAMA Neurology · 2026
16. Anterior cerebral artery variants and their influence on endovascular outcomes: a propensity score matched analysis from the CRETA registryNeuroradiology · 2026
17. Clinical Characteristics of 19 Patients With Acid Sphingomyelinase Deficiency: A Case Series From Multiple Centers in Argentina2026
18. Ankle Robotics Induces Ongoing Locomotor Plasticity with Delayed, Sustained Multi-Segmental Gait Improvements 17 Months After Training in Chronic StrokeMedicina · 2026
19. Disrupted Emotional Neural Synchrony in Schizophrenia Revealed by Intersubject Correlation of Naturalistic fMRINeuroImage · 2026
20. Recent Cochrane review has serious flaws: A perspective of clinicians and researchers from around the worldAlzheimer s & Dementia · 2026